Facilities adopting Envetec’s “GENERATIONS 1” technology for onsite treatment of biohazardous waste will now also have access to Enva’s services, including the collection and recycling of the treated material.
The technology treats biohazardous waste material – including plastics, glass, PPE, sharps containers and other general laboratory consumables – by turning it into a recyclable polymer flake for safe transporting.
The process is non-thermal and utilises a proprietary biodegradable chemical.
The companies hope that the partnership will help facilities across Ireland and the UK become more circular by treating their waste on site and ensuring it is collected for recycling.
In a joint statement, Envetec’s CEO, Malcolm Bell, and Enva’s CEO, James Priestley, commented: “Our respective companies recognise the urgent need to create a circular infrastructure for the treatment of biohazardous waste and reduce dependency on autoclaving, incineration and landfill.
“Through our collaboration, we are uniquely positioned to support customers by combining Envetec’s innovative technology with Enva’s leading recovery and recycling processes. Together, we aim to advance a more circular economy for managing biohazardous material while maximising both environmental stewardship and commercial benefits.”
The Irish healthcare sector generates approximately 2.83 megatons of CO2 annually, while the NHS in the UK contributes around 4-5% of the nation’s total emissions. These figures underscore the urgent need to adopt circular economy principles to address biohazardous material and mitigate its environmental impact.
Subscribe for free